Community

Advertising Opportunities

 Biotechnology Europe Programs

 Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

 

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

Terms of Business

Imprint

Privacy Policy

FAQ

Subscribe Newsletter

 

BIOTECHNOLOGY EUROPE EVENTS

   

 

 

   

 
 
   
   
   
 1 I 2 I 3  
The RPS conference 2010: Supporting patient and professional decision making
05-06 September 2010
How can pharmacists best support patients in their healthcare decisions? How can the profession be supported in dealing with workplace and commercial pressures while maintaining commitment to high quality patient care? These are just some of the issues that the Royal Pharmaceutical Society will address at its new conference in 2010.
 

 
Pharmaceutical Stability Testing Conference
15th and 16th September 2010
Pressure to ensure that the regulatory requirements for stability testing are fulfilled, first time has never been higher with the pharmaceutical industry as a whole focusing on cutting margins and avoiding recalls. This conference will feature a number of case studies where your fellow peers highlight how they have approached different aspects of Stability Testing to ensure efficiency and compliance.
 

 

Biomarkers in Clinical Trials
20th & 21st September 2010

SMi’s Biomarkers in Clinical Trials conference will present attendees with new concepts in biomarker application as well as a comprehensive review of recent developments. This unique event will bring together academics and industry professionals in order to provide a complete picture. There will be a strong focus on using biomarkers to bridge the gap between basic and applied research in drug development.

 

 
Pharmaceutical Pricing & Reimbursement in Turkey
22nd September-2010
Turkey is an exciting, high-growth potential market for pharmaceutical manufacturers. Market access however, is a complicated task in Turkey and requires an excellent understanding of all stakeholders' initiatives and views.
With a real intention to change the current situation and shape advanced processes: governmental bodies, the pharma industry and leading academics are strongly advocating initiatives such as HTA establishment and increasing transparency of reimbursement processes. Although the mission ahead is complicated and is raising a number of debates, it seems like the process has started and pricing and reimbursement models will be clearer in the short to medium terms.
 

 
Biosimilars & Biobetters
22nd & 23rd September 2010
Drawing on the strength of SMi's successful Generics, Supergenerics and Patent Strategies series, we are proud to present our inaugural Biosimilars & Biobetters conference taking place on the 22nd & 23rd September 2010 in London, UK. Book before the 28th May to save £300 on your place.
 

 
Advancing Clinical Research in Turkey, Middle East & North Africa
23th-24th September-2010
Industry sponsored clinical trials are increasingly conducted in emerging regions, due to escalating competition and high costs in the more established territories of North America and Western Europe. As companies search for advantages and new opportunities, factors such as large and eager patient populations, competitive trial budgets, and faster recruitment rates at fewer sites are prompting a fundamental geographic shift in the location of studies.
 

 
5th Annual Clinical Outsourcing Partnerships In Central & Eastern Europe
27th-28th September-2010
Central & Eastern Europe continues to be a standout region for high quality clinical research, with its well-trained investigators and large patient populations. Due to this popularity the clinical outsourcing environment in CEE & Russia is becoming more complex and difficult to navigate. This event will examine the multitude of outsourcing practices being used in the region today, as over the past 2-3 years several powerful yet inherently different outsourcing cultures have emerged in the region. These Preferred Provider and Functional Service Provider models have evolved in the region at varying levels of success and they both bring with them a multitude of opportunities and challenges for sponsors and clinical solution providers alike.
 

 
Optimizing Early Phase Oncology Studies to Accelerate Proof of Concept
29th-30th September-2010
When running early clinical trials for experimental new drugs across a range of therapeutic areas, demonstrating "proof of concept" is a critical milestone of the development process. It is at this stage where exploratory studies become confirmatory studies and there is a basis for studying the efficacy in a larger population. From a business perspective, showing proof of concept is also an essential bargaining chip when negotiating licensing agreements.
 

 

KOL: Knowledge Leader Partnerships
29th & 30th September 2010

This September, SMi offers the latest conference in its highly regarded series on KOL management – KOL: Knowledge Leader Partnerships.  Featuring presentations and panel debates from the key players in the industry, alongside views from agencies and the media, this conference is a must-attend event to discover how best to direct your Opinion Leader programme.

 

 
Amorphous Pharmaceutical Materials 2010
27th & 28th September 2010
Amorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid state development, partly due to the increasing proportion of insoluble drug molecules in development. Owing to the lack of an ordered crystal lattice, amorphous forms require minimal energy and therefore offer enhanced solubility, dissolution rate, and bioavailability - properties which are all integral to the effectiveness and success of future medicines.
 
 
 
 
 
 I back I top I
1 I 2 I 3

                                                                

office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com

 


 

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

About Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe


 

Biotechnology Europe Your Partner in Bioscience and Business

  Central Internet Platform and Service Company For The Life Sciences in Europe

Imprint I Site map I Privacy Policy I Contact us I About us I Copyright BIOTECHNOLOGY WORLD  All rights reserved